ES2042695T3 - Procedimiento para preparar una formulacion de crema a base de esteroides. - Google Patents
Procedimiento para preparar una formulacion de crema a base de esteroides.Info
- Publication number
- ES2042695T3 ES2042695T3 ES88118920T ES88118920T ES2042695T3 ES 2042695 T3 ES2042695 T3 ES 2042695T3 ES 88118920 T ES88118920 T ES 88118920T ES 88118920 T ES88118920 T ES 88118920T ES 2042695 T3 ES2042695 T3 ES 2042695T3
- Authority
- ES
- Spain
- Prior art keywords
- cream formulation
- beta
- alpha
- preparing
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000006071 cream Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- DXEXNWDGDYUITL-FXSSSKFRSA-N Tipredane Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@@](SC)(SCC)[C@@]1(C)C[C@@H]2O DXEXNWDGDYUITL-FXSSSKFRSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 239000003974 emollient agent Substances 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 229940075507 glyceryl monostearate Drugs 0.000 abstract 1
- 150000004668 long chain fatty acids Chemical class 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 abstract 1
- 239000001508 potassium citrate Substances 0.000 abstract 1
- 229960002635 potassium citrate Drugs 0.000 abstract 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 abstract 1
- 235000011082 potassium citrates Nutrition 0.000 abstract 1
- -1 skin conditioners Substances 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract 1
- 229940001584 sodium metabisulfite Drugs 0.000 abstract 1
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229950001669 tipredane Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/120,278 US4868169A (en) | 1987-11-13 | 1987-11-13 | Steroid cream formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2042695T3 true ES2042695T3 (es) | 1993-12-16 |
Family
ID=22389294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES88118920T Expired - Lifetime ES2042695T3 (es) | 1987-11-13 | 1988-11-14 | Procedimiento para preparar una formulacion de crema a base de esteroides. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4868169A (enExample) |
| EP (1) | EP0316834B1 (enExample) |
| JP (1) | JPH01153642A (enExample) |
| AT (1) | ATE77553T1 (enExample) |
| CA (1) | CA1326447C (enExample) |
| DE (1) | DE3872354T2 (enExample) |
| ES (1) | ES2042695T3 (enExample) |
| GR (1) | GR3005747T3 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110809A (en) * | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
| US5002938A (en) * | 1988-03-21 | 1991-03-26 | Bristol-Myers Squibb Company | Antifungal gel formulations |
| US4883792A (en) * | 1989-01-17 | 1989-11-28 | Peter Timmins | Steroid cream formulation |
| GB9106365D0 (en) * | 1991-03-26 | 1991-05-15 | Bioglan Lab Ltd | An emollient for use with ultraviolet light |
| US5432170A (en) * | 1991-07-16 | 1995-07-11 | Schering Aktiengesellschaft | Process for the production of semisolid preparations containing micronized active ingredients |
| JP2657982B2 (ja) * | 1992-12-24 | 1997-09-30 | ローン−プーラン・ロレ・リミテツド | 新規ステロイド |
| GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
| US20020173547A1 (en) | 1994-03-22 | 2002-11-21 | Jones Christopher Buchan | Pharmaceuticals compositions |
| CZ300146B6 (cs) * | 1995-03-17 | 2009-02-25 | Astrazeneca Uk Limited | Sterilní vodná kompozice obsahující emulzi typu olej ve vode a edetát |
| US6846846B2 (en) * | 2001-10-23 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin disinfectants |
| AU2003216213B2 (en) * | 2002-02-07 | 2008-10-02 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides |
| US7745425B2 (en) * | 2002-02-07 | 2010-06-29 | The Trustees Of Columbia University In The City Of New York | Non-irritating compositions containing zinc salts |
| US7879365B2 (en) * | 2002-02-07 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
| GB0219089D0 (en) * | 2002-08-16 | 2002-09-25 | Dow Corning | Silicone foam control compositions |
| FR2844448B1 (fr) | 2002-09-17 | 2006-06-23 | Lcw Les Colorants Wackherr | Methode de preparation extemporanee de compositions cosmetiques ayant la texture d'une creme, et compositions pour la mise en oeuvre de cette methode |
| CN102319409A (zh) * | 2003-07-17 | 2012-01-18 | 纽约市哥伦比亚大学托管会 | 含有季铵化合物及精油和/或精油成分的协同组合的抗微生物组合物 |
| US7759327B2 (en) * | 2006-01-06 | 2010-07-20 | The Trustees Of Columbia University In The City Of New York | Compositions containing zinc salts for coating medical articles |
| EP1973469A4 (en) * | 2006-01-20 | 2009-12-30 | Wisconsin Alumni Res Found | METHOD AND DEVICE FOR LOW-DOSED COMPUTER TOMOGRAPHY |
| US7801502B2 (en) * | 2006-12-18 | 2010-09-21 | Aai Corporation | Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems |
| US8361804B2 (en) * | 2008-09-29 | 2013-01-29 | M-I L.L.C. | Method and composition for determining hardness in wellbore fluid filtrate |
| US8409628B2 (en) | 2010-02-04 | 2013-04-02 | Penguin IP Holdings, Inc. | Methods and compositions for oxygenation of skin to treat skin disorders |
| US8900601B2 (en) | 2010-03-31 | 2014-12-02 | Jennifer Bartels | Permeable mixtures, methods and compositions for the skin |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3178345A (en) * | 1964-01-20 | 1965-04-13 | Upjohn Co | Topical steroid composition |
| US3892857A (en) * | 1972-11-24 | 1975-07-01 | Squibb & Sons Inc | Steroid formulation |
| GB1478009A (en) * | 1973-04-02 | 1977-06-29 | Glaxo Lab Ltd | Pharmaceutical compositions |
| US4361559A (en) * | 1981-08-20 | 1982-11-30 | E. R. Squibb & Sons, Inc. | Antiinflammatory 17,17-bis (substituted thio) androstenes |
| US4542129A (en) * | 1982-08-16 | 1985-09-17 | Norman Orentreich | DHEA Formulations and methods for treating dry skin |
-
1987
- 1987-11-13 US US07/120,278 patent/US4868169A/en not_active Expired - Lifetime
-
1988
- 1988-10-12 CA CA000579959A patent/CA1326447C/en not_active Expired - Lifetime
- 1988-11-11 JP JP63286604A patent/JPH01153642A/ja active Pending
- 1988-11-14 ES ES88118920T patent/ES2042695T3/es not_active Expired - Lifetime
- 1988-11-14 AT AT88118920T patent/ATE77553T1/de not_active IP Right Cessation
- 1988-11-14 DE DE8888118920T patent/DE3872354T2/de not_active Expired - Lifetime
- 1988-11-14 EP EP88118920A patent/EP0316834B1/en not_active Expired - Lifetime
-
1992
- 1992-09-22 GR GR920402073T patent/GR3005747T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3872354D1 (de) | 1992-07-30 |
| JPH01153642A (ja) | 1989-06-15 |
| DE3872354T2 (de) | 1992-12-10 |
| EP0316834B1 (en) | 1992-06-24 |
| CA1326447C (en) | 1994-01-25 |
| US4868169A (en) | 1989-09-19 |
| EP0316834A1 (en) | 1989-05-24 |
| GR3005747T3 (enExample) | 1993-06-07 |
| ATE77553T1 (de) | 1992-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2042695T3 (es) | Procedimiento para preparar una formulacion de crema a base de esteroides. | |
| ES2042725T3 (es) | Procedimiento para preparar inhibidores de 5-alfa-estersa de esteroide. | |
| ES8703727A1 (es) | Un metodo para preparar un producto ingerible de dulzor reducido. | |
| NO882417L (no) | Anti-inflammatorisk krempreparat. | |
| DE68909077D1 (de) | Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut. | |
| DK581185D0 (da) | Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre | |
| SE8901041D0 (sv) | Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning | |
| FI854167A0 (fi) | Mun- och tandvaordsmedel. | |
| ES2030017T3 (es) | Procedimiento para la preparacion de una composicion emulsion. | |
| ES544164A0 (es) | Un metodo para producir una presentacion visual de datos de examen de corrientes parasitas para la localizacion de defectos en un cuerpo. | |
| IE45678L (en) | Tissue specific protein. | |
| SE8800989L (sv) | Dietkomposition samt foerfarande foer framstaellning av densamma | |
| MX9207150A (es) | Metodo y composiciones para reducir la resistenciaa multiples farmacos. | |
| SE8800988D0 (sv) | Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same | |
| ZA784083B (en) | Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions | |
| GR3005443T3 (enExample) | ||
| SE8800990L (sv) | Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma | |
| GB1487543A (en) | Dermatological composition | |
| GB2150588A (en) | Shampoo for promoting growth of hair | |
| BR8204572A (pt) | Base para creme | |
| YU46838B (sh) | Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa | |
| IL37656A (en) | Method and compositions for comcombating marek's disease in poultry by the use of diphenyl sulfones and related compounds | |
| GB1487545A (en) | Dermatological composition | |
| PT84788B (pt) | Imunogenio isolado de moluscos, processo para a sua preparacao, reagentes para o diagnostico de bilharzioses humanas, vacinas contra as esquistosomiases e composicoes imunogenicas que contem o referido imunogenio | |
| NO912890L (no) | Preparat inneholdende salicylsyre for behandling av hudsykdommer med avskalling. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 316834 Country of ref document: ES |